Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.1%

12 terminated/withdrawn out of 235 trials

Success Rate

92.8%

+6.3% vs industry average

Late-Stage Pipeline

23%

53 trials in Phase 3/4

Results Transparency

6%

9 of 154 completed trials have results

Key Signals

27 recruiting9 with results11 terminated

Enrollment Performance

Analytics

N/A
89(48.6%)
Phase 2
29(15.8%)
Phase 3
28(15.3%)
Phase 4
25(13.7%)
Phase 1
10(5.5%)
Early Phase 1
2(1.1%)
183Total
N/A(89)
Phase 2(29)
Phase 3(28)
Phase 4(25)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (235)

Showing 20 of 235 trials
NCT06961578Not ApplicableRecruiting

SCORE Study: Comparing Surgery and Rigid Collar Treatment for Odontoid Fractures in Adults Over 70

Role: collaborator

NCT06414031Phase 3Recruiting

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Role: collaborator

NCT04931368Phase 3Active Not Recruiting

OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma

Role: collaborator

NCT05855499Not ApplicableActive Not Recruiting

Plasma On Chronic Wounds for Epidermal Regeneration

Role: collaborator

NCT03843385Phase 3Recruiting

Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis

Role: collaborator

NCT06845124Phase 2Recruiting

A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence

Role: collaborator

NCT07187518Not ApplicableRecruiting

Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device

Role: collaborator

NCT06938867Phase 1Recruiting

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Role: collaborator

NCT05260463Not ApplicableCompleted

LOQTEQ® Antibacterial Pre-Market Study

Role: collaborator

NCT02487576Not ApplicableCompleted

The CLOCK Study - A Human Dietary Intervention Study on Peripheral Circadian Clocks and Energy Metabolism

Role: collaborator

NCT00669266Recruiting

Adrenal Tumors - Pathogenesis and Therapy

Role: collaborator

NCT05360953Phase 2Suspended

Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin

Role: collaborator

NCT06054035Phase 4Recruiting

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

Role: collaborator

NCT06618729Not ApplicableCompleted

Effects of Plant-based Meat Alternatives in Comparison to Chicken Meat on Postprandial Metabolism in Healthy Adults

Role: collaborator

NCT06324695Not ApplicableCompleted

Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases

Role: collaborator

NCT05554835Recruiting

Global Registry and Natural History Study for Mitochondrial Disorders

Role: collaborator

NCT05597761Active Not Recruiting

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)

Role: collaborator

NCT06967831Recruiting

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

Role: collaborator

NCT05658172Not ApplicableRecruiting

Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer

Role: collaborator

NCT06061094Phase 2Recruiting

Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

Role: collaborator